Ibandronate Sodium Injection, Solution
Product Images NDC 62756-218

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 62756-218). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ibandronate-fig1 (Figure 1)

Ibandronate-fig1 (Figure 1)
The text describes a figure showing the mean percent change in Lumbar Spine BMD at one year in patients treated with Ibandronate Sodium Tablets or Injection. The figure compares the effect of the two treatments and shows statistically significant improvement in the group treated with Ibandronate Sodium Injection at a dose of 3mg every 3 months.*
FDA Label Image

Showbox (Showbox)

Showbox (Showbox)
This is a description of a medication called Ibandronate Sodium Injection which is used for intravenous administration. Each vial contains a 3mL solution containing 3.375mg ibandronate monosodium monohydrate, equivalent to 3mg free acid along with other ingredients. It is manufactured by Sun Pharmaceutical Industries Ltd. It should be stored at 20° to 25°C (68° to 77°F) and unused portions should be discarded. The medication should be administered per the directions in the accompanying prescribing information. One 3 mL single dose vial is included.*
FDA Label Image

Vial-label (Vial Label)

Vial-label (Vial Label)
This is a description of a vial containing ibandronate monosodium medication for intravenous use. The vial has a strength of 375 mg and contains 3 mL of solution. The solution also includes sodium chloride, sodium acetate, trinydrate, glacial acetic acid, and water. The dosage recommended for use is 15 to 30 seconds. More information can be obtained from the accompanying prescription information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.